Chinese Journal of Blood Purification ›› 2025, Vol. 24 ›› Issue (11): 942-945.doi: 10.3969/j.issn.1671-4091.2025.11.014

Previous Articles     Next Articles

Hemodiafiltration: Cardioprotective hemodialysis

DU Hui1,  ZUO Li   

  1. Global Medical Office, Fresenius Medical Care, Beijing 100028, China; 2Department of Nephrology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2025-04-03 Revised:2025-05-08 Online:2025-11-12 Published:2025-11-12
  • Contact: 100044 北京,2北京大学人民医院肾内科 E-mail:zuoli@bjmu.edu.cn

Abstract: Hemodiafiltration (HDF) is a dialysis technique that combines the principles of diffusion and convection. Cardiovascular disease is the leading cause of death among dialysis patients, accounting for approximately 32% to 55.9% of all-cause mortality. Studies have shown that HDF can significantly reduce the risk of cardiovascular death. The potential mechanisms include enhancing hemodynamic stability, effectively removing uremic toxins, correcting electrolyte disturbances, and alleviating inflammation and oxidative stress. In addition, HDF may also effectively ameliorate anemia and improve malnutrition, thereby further reducing the risk of cardiovascular events. This article reviews the research evidence and potential mechanisms of HDF in cardiovascular protection.

Key words: Hemodialysis, Hemodiafiltration, Cardiovascular protection

CLC Number: